Oral administration of somatostatin reduces postprandial plasma triglycerides, gastrin and gut glucagon-like immunoreactivity
- 1 April 1979
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 24 (17) , 1595-1600
- https://doi.org/10.1016/0024-3205(79)90021-3
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- INHIBITION OF CHOLECYSTOKININ-PANCREOZYMIN RELEASE BY SOMATOSTATINThe Lancet, 1977
- Hypothesis: Physiologic role of pancreatic somatostatin and the contribution of D-cell disorders to diabetes mellitusLife Sciences, 1977
- Effect of somatostatin on meal-stimulated pancreatic exocrine secretions in dogsDiabetes, 1977
- The Effect of Somatostatin on Release and Insulinotropic Action of Gastric Inhibitory PolypeptideCanadian Journal of Physiology and Pharmacology, 1975
- Somatostatin: Abundance of Immunoreactive Hormone in Rat Stomach and PancreasScience, 1975
- Letter: Immunohistochemical localization of somatostatin in the rat pancreas.Journal of Histochemistry & Cytochemistry, 1975
- DIRECT INHIBITION OF GASTRIC ACID AND PEPSIN SECRETION BY GROWTH-HORMONE RELEASE-INHIBITING HORMONE IN CATSThe Lancet, 1975
- INHIBITION OF GASTRIN AND GASTRIC-ACID SECRETION BY GROWTH-HORMONE RELEASE-INHIBITING HORMONEThe Lancet, 1974
- Eine neue Bestimmung der Neutralfette im Blutserum und GewebeKlinische Wochenschrift, 1966
- IMMUNOASSAY OF ENDOGENOUS PLASMA INSULIN IN MANJournal of Clinical Investigation, 1960